Advicenne announced the appointment of Charlotte Sibleyas Independent Director to its Board of Directors and Paul Michalet as Chief Financial Officer. Ms. Sibley's career in the healthcare industry spans 40 years. Her career includes contributing her expertise in market research at Pfizer, and in the medical device sector at Johnson & Johnson.

Ms. Sibley also expanded her expertise to global pharma at Bristol-Myers Squibb and Pharmacia (now Pfizer), in biotech at Millennium Pharmaceuticals (now Takeda Oncology), and in consumer products at Lipton. She established the U.S. operations for a leading UK-based market research company, achieving profitability in 18 months in a highly competitive environment. Mr. Michalet is a member of the SFAF (France Society of Financial Analysts) and of the IFA (French Institute of Board Directors).

During the course of Mr. Michalet's career, he has held various senior executive positions over the last 30 years. He served as Chief Financial Officer for 10 years in the manufacturing and service industries and, during the past 20 years, held senior executive positions in biotechnology companies in the chemical, cosmetics and pharmaceutical industries. He most recently was Chief Executive Officer of a private biotech company specializing in monoclonal antibodies development for oncology and was previously Chief Financial Officer and Chief Business Officer for Fermentalg.